Real-time enrollment status for this ovarian neoplasms clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 5:58 AM UTC
| NCT Number | NCT06751329 |
| Recruiting Status | Recruiting |
| Condition | Ovarian Neoplasms |
| Phase | PHASE1 |
| Target Enrollment | 280 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Xadcera Biopharmaceutical (Suzhou) Co., Ltd. |
| Last Updated on CT.gov | August 7, 2026 (3 weeks ago) |
As of September 1, 2026: Clinical trial NCT06751329 is currently recruiting participants. This phase1 study for ovarian neoplasms is actively seeking new participants at 4 locations across the United States. The study is sponsored by Xadcera Biopharmaceutical (Suzhou) Co., Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06751329 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06751329 was last updated 3 weeks ago (August 7, 2026). HelloStudys verifies this status automatically.